These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7862719)

  • 1. Preference for high- versus low-potency marijuana.
    Chait LD; Burke KA
    Pharmacol Biochem Behav; 1994 Nov; 49(3):643-7. PubMed ID: 7862719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delta-9-tetrahydrocannabinol content and human marijuana self-administration.
    Chait LD
    Psychopharmacology (Berl); 1989; 98(1):51-5. PubMed ID: 2543018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reinforcing and subjective effects of oral delta 9-THC and smoked marijuana in humans.
    Chait LD; Zacny JP
    Psychopharmacology (Berl); 1992; 107(2-3):255-62. PubMed ID: 1319601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marijuana's dose-dependent effects in daily marijuana smokers.
    Ramesh D; Haney M; Cooper ZD
    Exp Clin Psychopharmacol; 2013 Aug; 21(4):287-93. PubMed ID: 23937597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reinforcing effects of oral Delta9-THC in male marijuana smokers in a laboratory choice procedure.
    Hart CL; Haney M; Vosburg SK; Comer SD; Foltin RW
    Psychopharmacology (Berl); 2005 Sep; 181(2):237-43. PubMed ID: 15830233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dronabinol and marijuana in HIV(+) marijuana smokers: acute effects on caloric intake and mood.
    Haney M; Rabkin J; Gunderson E; Foltin RW
    Psychopharmacology (Berl); 2005 Aug; 181(1):170-8. PubMed ID: 15778874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are choice and self-administration of marijuana related to delta 9-THC content?
    Kelly TH; Foltin RW; Emurian CS; Fischman MW
    Exp Clin Psychopharmacol; 1997 Feb; 5(1):74-82. PubMed ID: 9234042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subjective and physiological effects, and expired carbon monoxide concentrations in frequent and occasional cannabis smokers following smoked, vaporized, and oral cannabis administration.
    Newmeyer MN; Swortwood MJ; Abulseoud OA; Huestis MA
    Drug Alcohol Depend; 2017 Jun; 175():67-76. PubMed ID: 28407543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study.
    van der Pol P; Liebregts N; Brunt T; van Amsterdam J; de Graaf R; Korf DJ; van den Brink W; van Laar M
    Addiction; 2014 Jul; 109(7):1101-9. PubMed ID: 24628797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of delta 9-THC on marijuana smoking, dose choice, and verbal report of drug liking.
    Kelly TH; Foltin RW; Emurian CS; Fischman MW
    J Exp Anal Behav; 1994 Mar; 61(2):203-11. PubMed ID: 8169569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids.
    Ilan AB; Gevins A; Coleman M; ElSohly MA; de Wit H
    Behav Pharmacol; 2005 Sep; 16(5-6):487-96. PubMed ID: 16148455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans.
    Wachtel SR; ElSohly MA; Ross SA; Ambre J; de Wit H
    Psychopharmacology (Berl); 2002 Jun; 161(4):331-9. PubMed ID: 12073159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of subjective, pharmacokinetic, and physiological effects of marijuana smoked as joints and blunts.
    Cooper ZD; Haney M
    Drug Alcohol Depend; 2009 Aug; 103(3):107-13. PubMed ID: 19443132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An MR-compatible device for delivering smoked marijuana during functional imaging.
    Frederick Bd; Lindsey KP; Nickerson LD; Ryan ET; Lukas SE
    Pharmacol Biochem Behav; 2007 May; 87(1):81-9. PubMed ID: 17521714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetrahydrocannabinol content and differences in marijuana smoking behavior.
    Herning RI; Hooker WD; Jones RT
    Psychopharmacology (Berl); 1986; 90(2):160-2. PubMed ID: 3024196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of varying marijuana potency on deposition of tar and delta9-THC in the lung during smoking.
    Matthias P; Tashkin DP; Marques-Magallanes JA; Wilkins JN; Simmons MS
    Pharmacol Biochem Behav; 1997 Dec; 58(4):1145-50. PubMed ID: 9408226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cumulative dosing procedure for administering marijuana smoke to humans.
    Chait LD; Corwin RL; Johanson CE
    Pharmacol Biochem Behav; 1988 Mar; 29(3):553-7. PubMed ID: 3362949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid antagonism of cannabinoid effects: differences between marijuana smokers and nonmarijuana smokers.
    Haney M
    Neuropsychopharmacology; 2007 Jun; 32(6):1391-403. PubMed ID: 17091128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tetrahydrocannabinol content on marijuana smoking behavior, subjective reports, and performance.
    Heishman SJ; Stitzer ML; Yingling JE
    Pharmacol Biochem Behav; 1989 Sep; 34(1):173-9. PubMed ID: 2560548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral and subjective effects of marijuana following partial sleep deprivation.
    Liguori A; Gatto CP; Jarrett DB; McCall WV; Brown TW
    Drug Alcohol Depend; 2003 Jun; 70(3):233-40. PubMed ID: 12757961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.